Sood Anil K, Abu-Rustum Nadeem R, Barakat Richard R, Bodurka Diane C, Brown Jubilee, Donato Michele L, Poynor Elizabeth A, Wolf Judith K, Gershenson David M
Department of Gynecologic Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77230-1439, USA.
Gynecol Oncol. 2005 Jun;97(3):916-23. doi: 10.1016/j.ygyno.2005.03.013.
This paper provides a summary of the presentations given at the Fifth International Conference on Ovarian Cancer in Houston, Texas on December 1-4, 2004.
The focus of this meeting was to discuss the most current information regarding development, progression, diagnosis, and therapy of ovarian cancer. The presentations at this conference were grouped into 7 sessions, and are summarized in this paper as follows: ovarian cancer biology, novel therapeutic approaches, surgical and pathological controversies, quality of life/biobehavioral aspects of ovarian cancer, screening/prevention approaches, management of uncommon ovarian cancers, and treatment controversies.
While many challenges remain in the overall management of ovarian carcinoma, the speakers at this conference reviewed the opportunities available to scientists and clinicians to work collaboratively to make advances.
本文总结了2004年12月1日至4日在得克萨斯州休斯敦举行的第五届国际卵巢癌会议上的发言内容。
本次会议的重点是讨论有关卵巢癌发生、发展、诊断和治疗的最新信息。本次会议的发言分为7个部分，本文总结如下：卵巢癌生物学、新型治疗方法、手术与病理争议、卵巢癌的生活质量/生物行为方面、筛查/预防方法、罕见卵巢癌的管理以及治疗争议。
虽然卵巢癌的整体管理仍存在许多挑战，但本次会议的发言者回顾了科学家和临床医生合作取得进展的机会。
